The introduction of nicotinamide being a nicotine replacement in e-cigarette and smokeless goods signifies a major regulatory problem with the FDA. Nicotinamide does not have nicotinic receptor agonist activity and is understood to act as a sedative at superior dosages6. The promises produced by Nic